Kiniksa Pharmaceuticals International, plc Variable Lease, Cost
Kiniksa Pharmaceuticals International, plc (KNSA) reported Variable Lease, Cost of $894.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-24
- Kiniksa Pharmaceuticals International, plc variable lease, cost for the quarter ending 2023-12-31 was $160.00K.
- Kiniksa Pharmaceuticals International, plc variable lease, cost for the quarter ending 2023-09-30 was $466.00K.
- Kiniksa Pharmaceuticals International, plc variable lease, cost for the quarter ending 2023-06-30 was $177.00K, a 96.67% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc variable lease, cost for the quarter ending 2022-12-31 was $0.00.
- Kiniksa Pharmaceuticals International, plc variable lease, cost for fiscal 2025 was $894.00K, a 26.27% increase from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc variable lease, cost for fiscal 2024 was $708.00K, a 30.79% decline from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc variable lease, cost for fiscal 2023 was $1.02M, a 675.00% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc variable lease, cost for fiscal 2022 was $132.00K, a 54.01% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $894.00K 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $708.00K 10-K · filed 2026-02-24 | |||
| 2023-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $626.00K derived: sum of 2 quarters · filed 2026-02-24 | $803.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.02M 10-K · filed 2026-02-24 |
| 2023-09-30 | $466.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $643.00K derived: sum of 2 quarters · filed 2023-11-02 | $863.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $177.00K 10-Q · filed 2023-08-01 | $397.00K 10-Q · filed 2023-08-01 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$38.00K derived: sum of 2 quarters · filed 2025-02-25 | $52.00K derived: sum of 3 quarters · filed 2025-02-25 | $132.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $52.00K derived: sum of 2 quarters · filed 2023-11-02 | $132.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $90.00K 10-Q · filed 2023-08-01 | $170.00K 10-Q · filed 2023-08-01 | ||
| 2021-12-31 | $287.00K 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $65.00K derived: sum of 2 quarters · filed 2023-03-02 | $117.00K derived: sum of 3 quarters · filed 2023-03-02 | $167.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $30.00K 10-Q · filed 2020-11-05 | $82.00K derived: sum of 2 quarters · filed 2020-11-05 | $132.00K 10-Q · filed 2020-11-05 | $123.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $52.00K 10-Q · filed 2020-08-04 | $102.00K 10-Q · filed 2020-08-04 | $93.00K derived: sum of 3 quarters · filed 2022-02-24 | $145.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $50.00K 10-Q · filed 2020-05-04 | $41.00K derived: sum of 2 quarters · filed 2022-02-24 | $93.00K derived: sum of 3 quarters · filed 2022-02-24 | $180.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $43.00K derived: sum of 2 quarters · filed 2022-02-24 | $130.00K derived: sum of 3 quarters · filed 2022-02-24 | $152.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $52.00K 10-Q · filed 2020-11-05 | $139.00K derived: sum of 2 quarters · filed 2020-11-05 | $161.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $87.00K 10-Q · filed 2020-08-04 | $109.00K 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $22.00K 10-Q · filed 2020-05-04 |